Potentially effective and life-saving treatment for patients with systemic amyloidosis relies on the astute clinician recognizing the signs and symptoms, histochemical identification of fibrils, and accurate diagnosis of amyloid type. In this issue of Blood, Brambilla et al report a new methodology for accomplishing the key third step in this process.
CITATION STYLE
Seldin, D. C., & Sanchorawala, V. (2012, February 23). Amyloidomics comes of age. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-10-381178
Mendeley helps you to discover research relevant for your work.